期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

高海拔地区重组人脑钠肽治疗慢性心功能不全的疗效观察

下载PDF
导出
作者 张青 吴红 马海英 李顺延
机构地区 青海省第五人民医院心内科
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第21期2801-2802,共2页 Chinese Journal of Gerontology
关键词 脑钠肽 慢性心功能不全 老年人 高海拔地区
分类号 R544.1 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

  • 1毛拥军,张春华,刘松,陈祥鸿.脑钠肽与充血性心力衰竭的治疗[J].中华心血管病杂志,2004,32(9):855-857. 被引量：47
  • 2Rademaker MT, Charles C J, Espiner EA, et al. Combined inhibition of angiotensin Ⅱ and endothelin suppresses the brain natriuretie peptide response to developing heart failure [ J]. Clin Sci ( Lond ) , 2004 ; 14 : 569- 76.
  • 3Sudoh T, Kangawa K, Minamnio N, et al. A new natriuretic peptidein porcine brain[ J]. Nature,1988 ;532:78- 81.
  • 4Yoshimura M, Yasue H, Ogawa H. Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure [J]. Can J Physiol pharmaacol,2001 ;79:730-5.
  • 5Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure:prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction [ J]. Circulation, 1997 ;96(2) :509-16.
  • 6Abraham WT, Lowes BD, Ferguson DA, et al. Systemic hemodynamic, neurohormonal and renal effects of a steadystate infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure[ J]. J Card Fail, 1998 ;4:37-44.
  • 7Mills RM, Le Jemtel TH, Horton DP, et al. Sustained hemodynamic effects of an infusion of nesiritide in heart failure[ J]. J Am Coll Cardiol, 1999 ; 34:155-62.

二级参考文献15

  • 1高伟,王士雯,赵玉生.脑钠肽前体N末端片段在心血管病研究应用中的现状[J].中华心血管病杂志,2004,32(8):759-761. 被引量：65
  • 2Sagnella GA.Mearement and significance of circulating natriuretic peptides in cardiovascular disease.Clin Sci,1998,95:519-529.
  • 3Hystad ME,Geiran OR,Attramadal H,et al.Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure.Acta Physiol Scand,2001,171:395-403.
  • 4Goto T,Takase H,Toriyama T,et al.Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.Heart,2003,89:1303-1307.
  • 5Hobbs RE,Miller LW,Bott-Silverman C,et al.Hemodynamic effects of a single Intravenous Injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.Am J Cardiol,1996,78:896
  • 6Mills RM,LeJemtel TH,Horton DP,et al.Sustainded hemodynamic effects of an Infusion of nesiritide(human B-type natriuretic peptide)in heart failure.J Am Coll Cardiol,1999,34:155-162.
  • 7Colucci WS,Elkayam U,Horton DP,et al.Intravenous nesiritide,a natriuretic peptide,in the treatment of decompensated congestive heart failure.N Engl J Med,2000,343:896.
  • 8Burger AJ,Elkayam U,Neibaur MT,et al.Comparison of the occurrence of ventricular arrhythmias in patients with acutely decornpensated congestive heart failure receiving dobutamine versus nesiritide therapy.Am J Cardiol,2001,88 :35-39.
  • 9Publication Committee for the VMAC Investigators.Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure-a randomized controlled trial.JAMA,2002,287:1531-1535.
  • 10U.S.Food and Drug Administration.The Food and Drug Administration( FDA)has approved Natrecor(nesiritide)Injection for the treatment of acute congestive heart failure(CHF).New York:FDA Talk Paper,2001.T01-T36.

共引文献46

中国老年学杂志
2009年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部